showed that the expression of the full-length HNF1B transcript is non-significantly slightly lower (approximately 0.8 ×), and the expression of the 3p variant is significantly higher (approximately 7 ×) in 21 prostate adenocarcinoma tissue samples when compared with 39 non-malignant (benign hyperplasia) tissues (by qPCR normalization to B2M and GUSB reference mRNA transcripts)24. This evidence concerns the gene HNF1B and prostate adenocarcinoma.